• 10074-G5 c-Myc Inhibitor: Workflows & Troubleshooting in Can

  2026-05-13

  10074-G5, a potent small-molecule c-Myc inhibitor from APExBIO, enables precise disruption of c-Myc/Max dimerization, advancing apoptosis and tumor regression studies. This guide delivers actionable protocol enhancements and troubleshooting insights for translational cancer models targeting aggressive oncogenic pathways.

• Anagliptin (SK-0403): Mechanistic Insights for Precision Vas

  2026-05-13

  Explore how Anagliptin (SK-0403) enables precision in vascular and glycemic research through selective DPP-4 inhibition and novel mechanistic findings. Gain unique assay guidance and methodological clarity, distinct from protocol-focused literature.

• Red Blood Cell Cytoplasmic Membrane Bending Rigidity Reveale

  2026-05-12

  This study provides a direct measurement of the bending rigidity of the red blood cell cytoplasmic membrane, using X-ray, neutron, and simulation techniques to clarify a longstanding biophysical question. The findings refine our understanding of red cell membrane mechanics and offer new benchmarks for membrane-focused biomedical research.

• Validated HPLC for Trelagliptin Succinate and Impurity Profi

  2026-05-12

  This study introduces a validated HPLC method for quantifying trelagliptin succinate (SYR-472 succinate) and its related impurities in pharmaceutical dosage forms. The robust assay addresses the lack of official monographs and enables reliable quality control, supporting further diabetes mellitus research and formulation development.

• Trelagliptin Succinate: Beyond Glycemic Control in Diabetes

  2026-05-11

  Explore how Trelagliptin succinate, a potent DPP-4 inhibitor, uniquely advances type 2 diabetes research and bone biology. This article uncovers novel mechanistic insights and protocol guidance not found elsewhere.

• YC-1: Unraveling Post-Transcriptional HIF-1α Control in Tumo

  2026-05-11

  Discover how YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol empowers advanced cancer research through precise post-transcriptional HIF-1α inhibition and angiogenesis modulation. This article provides a uniquely mechanistic and protocol-driven guide to optimizing apoptosis and hypoxia pathway assays.

• Bovine Insulin for Cell Culture: Protocols, Applications, an

  2026-05-10

  Bovine insulin from APExBIO is more than a standard supplement—it is a precision tool for elevating cell proliferation, dissecting insulin signaling, and enabling advanced metabolic modeling. This article guides scientists through actionable experimental workflows, troubleshooting, and the latest mechanistic insights, positioning bovine insulin as essential for high-impact research.

• Mavorixafor Hydrochloride: CXCR4 Antagonist for Protoplast-B

  2026-05-09

  Explore how Mavorixafor hydrochloride, a potent CXCR4 antagonist, enables advanced protoplast-based research and assay innovation. This article uniquely bridges chemokine signaling with membrane biology, providing new workflow strategies for scientists.

• Ibrexafungerp and Caspofungin: Efficacy in Resistant Candida

  2026-05-08

  Wiederhold et al. provide robust evidence that ibrexafungerp, a novel triterpenoid, exhibits strong in vitro and in vivo activity against fluconazole-resistant Candida auris, even with delayed treatment initiation. The study also benchmarks the continued relevance of caspofungin, a lipopeptide antifungal drug, in targeting β-(1,3)-D-glucan biosynthesis for antifungal therapeutics.

• Tobramycin: Aminoglycoside Antibiotic Powering Resistance Re

  2026-05-08

  Tobramycin stands out as a water-soluble aminoglycoside antibiotic, enabling precise, reproducible workflows for studying Gram-negative bacteria and resistance mechanisms. Backed by comparative data and robust purity verification, it is a cornerstone for advanced microbiology research and assay optimization.

• TBK1 Inhibition Mitigates Painful Diabetic Neuropathy via Mi

  2026-05-07

  Liao et al. (2024) reveal that TANK-binding kinase 1 (TBK1) plays a central role in mediating microglia pyroptosis and pain hypersensitivity in diabetic neuropathy. Their mechanistic study demonstrates that TBK1 inhibition, either via siRNA or amlexanox, significantly alleviates neuropathic pain, highlighting a promising therapeutic strategy for painful diabetic neuropathy (PDN).

• Surfactant-Derived Lipid Nanoparticles for mRNA Delivery to

  2026-05-07

  This study introduces a dual-component lipid nanoparticle platform leveraging a surfactant-derived ionizable lipid for efficient mRNA delivery to hard-to-transfect macrophages. Through systematic structure–function optimization, the approach achieves nuclease protection and high biocompatibility, offering a new route for engineering immune cell function.

• CHI3L1 Inhibition Restores Astrocyte Function in Alzheimer's

  2026-05-06

  This study elucidates how Compound Z17 (CHI3L1-IN-5) selectively inhibits chitinase-3-like protein 1 (CHI3L1), a key neuroinflammatory driver in Alzheimer's disease. By blocking CHI3L1 and associated NF-κB signaling, Z17 restores amyloid-beta uptake and lysosomal function in human astrocytes, supporting its promise as a dual-action research tool for neurodegeneration models.

• A-1331852: Advancing BCL-XL Inhibition for Senolytic Precisi

  2026-05-06

  This thought-leadership article explores the mechanistic and translational significance of A-1331852, a potent BCL-XL inhibitor, in the context of apoptosis research and senolytic therapy. Integrating mechanistic insights, recent peer-reviewed findings, and practical protocol guidance, it offers strategic direction for translational researchers aiming to eradicate chemotherapy-induced senescent cancer cells and improve therapeutic outcomes.

• PF-562271 HCl: Enhancing FAK/Pyk2 Inhibition in Cancer Resea

  2026-05-05

  PF-562271 HCl is redefining cancer research workflows by delivering high-potency, selective FAK/Pyk2 inhibition, enabling precise dissection of tumor growth and microenvironment. This article translates the latest experimental strategies and troubleshooting insights into hands-on guidance for researchers aiming to maximize assay reproducibility and translational relevance.

396 records 8/27 page Previous Next First page 上5页 678910 下5页 Last page